Furthermore, 30% of breast cancer patients without heredity were found to have methylation of the BRCA1 and BRCA2 promoter or dysfunctional upstream pathways, leading to descending levels of BRCA1 and BRCA2 (10, 11). The gene discussed is BRCA1; the disease is breast cancer.